*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Boston Globe | Posted: January 19, 2011
Angela Levin
CISTP
Contact Angela Levin
404-894-3199
Summary Sentence:
Boston Globe article, "$1b effort yields no bioterror defenses"
Full Summary:
Professor Margaret E. Kosal was recently cited on biodefense policy and funding by the Pentagon, in an article in the Boston Globe.
Margaret E. KosalProfessor Margaret E. Kosal was recently cited on biodefense policy and funding by the Pentagon, in an article in the Boston Globe.
"There is a fundamental need for basic science. The low-hanging fruit has all been picked," said Margaret Kosal, Assistant Professor in the Sam Nunn School of International Affairs, about the limitations of genetic science that have prevented the success of the Pentagon’s program to develop treatments for troops and civilians infected in a germ warfare attack. Kosal worked on the program between 2006 and 2007.
Margaret E. Kosal is an Assistant Professor at The Sam Nunn School of International Affairs. Prof. Kosal is the Program Co-Director for the Emerging Technology and Security program, and the Director of the Biological and Chemical on Proliferation and Counterterrorism program.
**Read full article in Boston Globe - January 17, 2011.
